ENLIVEX THERAPEUTICS LTD ENLV 深 滬
已收盤 01-30 16:00:00 美东时间
1.01
-0.030
-2.88%
華盛通- 最 高1.04
- 今 開1.00
- 成交量 35.68万股
- 最 低 0.99
- 昨 收 1.04
- 總市值 2409.69万
- 52周最高 2.10
- 市盈率 靜 --
- 換手率 1.50%
- 52周最低 0.66
- 委 比 90.91%
- 總股本 2385.83万
- 歷史最高 44.90
- 量 比 0.69
- 振 幅 4.81%
- 歷史最低 0.66
- 每 手 1
- 風險率 0.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Enlivex Lists RAIN Treasury Token on WhiteBIT to Boost Liquidity
Enlivex ( ($ENLV) ) has provided an update. On January 26, 2026, Enlivex announ...
01-26 21:27
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange
Enlivex Therapeutics Ltd. announced the listing of its primary treasury asset, the RAIN token, on the WhiteBIT cryptocurrency exchange, enhancing market access and liquidity for RAIN. RAIN is a governance and utility token for a decentralized predictions and options protocol on the Arbitrum network. Enlivex focuses on late-stage clinical development of Allocetra™ for treating osteoarthritis, impacting millions globally with limited treatment opti...
01-26 13:00
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
Enlivex Therapeutics Ltd. announced its plan to voluntarily delist its ordinary shares from the Tel Aviv Stock Exchange (TASE) to streamline operations, reduce administrative costs, and enhance liquidity on Nasdaq. The last day of trading on TASE is expected to be April 23, 2026, with delisting on April 26, 2026. The shares will remain listed on Nasdaq under the symbol "ENLV," and the company will continue filing SEC reports. The move aims to foc...
01-23 13:00
Analyst Sees Massive Upside For Penny Stock Enlivex After RAIN Token Gains Momentum
Enlivex's RAIN token begins trading on KuCoin as analysts raise price targets, citing growing prediction markets and token burn mechanics.
01-15 00:46
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange
Enlivex Therapeutics Ltd. announced the listing of its RAIN token on KuCoin, a major global cryptocurrency exchange with over 40 million users, enhancing market access and liquidity for its digital treasury asset. KuCoin, founded in 2017, ranks among the top ten exchanges globally, offering deep liquidity and various trading products. The move is expected to support Enlivex's treasury strategy and expand RAIN's global presence. RAIN serves as the...
01-07 13:00
Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development
Enlivex Therapeutics will host a virtual fireside chat on December 11, 2025, at 11:00 am ET. Shai Novik, the company's Executive Chairman, will discuss updates following the recent $212 million private placement, including the launch of a digital asset treasury strategy focused on RAIN token accumulation and the advancement of Allocetra's clinical development for treating osteoarthritis. The event will include a Q&A session, and a recording will ...
2025-12-04 13:00
Enlivex Completes $212 Million Private Placement, Expands Digital Asset Strategy
Enlivex ( ($ENLV) ) just unveiled an announcement. On November 24, 2025, Enlive...
2025-11-26 21:28
3 Penny Stocks to Watch Now, 11/25/25
Antelope Enterprise Holdings, Enlivex Therapeutics, and Inno Holdings are the 3...
2025-11-25 23:13
D. Boral Capital Downgrades Enlivex Therapeutics to Hold
D. Boral Capital analyst Jason Kolbert downgrades Enlivex Therapeutics (NASDAQ:ENLV) from Buy to Hold.
2025-11-24 23:41
